Paul Alain TAGNOUOKAM NGOUPO

Dr. Paul Alain TAGNOUOKAM NGOUPO

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2023 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
MYMoïse Henri Moumbeket Yifomnjou
Moïse Henri Moumbeket Yifomnjou
GMGwladys Chavely Monamele
Gwladys Chavely Monamele
MNMohamadou Njankouo‐Ripa
Mohamadou Njankouo‐Ripa
AMAbdou Fatawou Modiyinji
Abdou Fatawou Modiyinji
PNPaul Alain TAGNOUOKAM NGOUPO
Paul Alain TAGNOUOKAM NGOUPO
RNRichard Njouom
Richard Njouom
Background: Acute lower respiratory tract infections (ALRIs) are one one of the leading causes of morbidity and mortality among people of all ages worldwide, particularly in low‐ and middle‐income countries (LMICs). The purpose of this study was to determine epidemiological characteristics of respiratory viruses in acute respiratory infection (ARI) patients during the COVID‐19 pandemic in Yaoundé, Cameroon.Methods: Patients were monitored for respiratory symptoms as part of the surveillance of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and other respiratory viral infections. Patients of all ages with respiratory symptoms less than 5 days were considered. Sociodemographic and clinical data as well as nasopharyngeal samples was collected from patients. Nasopharyngeal samples were tested for SARS‐CoV‐2, influenza, and respiratory syncytial virus (RSV) using real‐time reverse‐transcription polymerase chain reaction methods. Virus distribution and demographic data were analyzed with R version 2.15.1.Results: From July 2020 to October 2021, 1120 patients were included. The overall viral detection rate was 32.5%, including 9.5% for RSV, 12.6% for influenza virus and 12.8% for SARS‐CoV‐2. Co‐infections were detected in 6.9% of positive cases. While RSV and influenza virus showed seasonal trends, SARS‐CoV‐2 was detected throughout the study period.Conclusion: We found that during COVID‐19 pandemic, respiratory viruses play an important role in etiology of influenza‐like illness in Cameroon, and this observation was true for patients of all ages.


9 August 2019 in Virology Journal
Verified
Journal Article
Open access
PDF file
PNPaul Alain TAGNOUOKAM NGOUPO
Paul Alain TAGNOUOKAM NGOUPO
MNMarie Nicole Ngoufack
Marie Nicole Ngoufack
SKSebastien Kenmoe
Sebastien Kenmoe
SLSimon Frédéric Lissock
Simon Frédéric Lissock
MAMarie Amougou-Atsama
Marie Amougou-Atsama
RNRichard Njouom
Richard Njouom
Current HCV treatments are genotype specific although potential pan-genotype treatments have recently been described. Therefore, genotyping is an essential tool for the therapeutic management of HCV infection and a variety of technologies have been developed for HCV genotypes determination. Sequences analysis of HCV sub-genomic regions is considered as gold standard and is widely used for HCV genotyping. Here, we compared HCV genotyping using core and NS5B regions in routine practice in HCV-positive Cameroonian patients. All plasma samples received at Centre Pasteur of Cameroon (CPC) in 2016 for HCV genotyping were included. Viral loads were determined using the Abbott Real Time assay. Further, genotyping was based on the amplification and sequencing of core and NS5B regions following by phylogenetic analysis of corresponding sequences. A total of 369 samples were received during the study period with high viral load values (median: 930,952 IU/ml; IQR: 281,833-2,861,179). Positive amplification was obtained in at least one genomic region (core or NS5B) for all the samples with similar amplification rate in the two genomic regions (p = 0.34). Phylogenetic analysis showed that among the 369 samples, 146 (39.6%) were classified as genotype 4, 132 (35.8%) as genotype 1, 89 (24.1%) as genotype 2, in both core and NS5B regions. Interestingly, for two samples (0.54%) discordant genotypes were obtained in both regions with the core region classified as genotype 4 while the NS5B was identified as genotype 1 indicating the presence of putative HCV recombinant virus or multiple infections in these samples. Discrimination of HCV subtypes was most likely possible with NS5B compared to core region. We found high amplification rates of HCV in both core and NS5B regions, and a good concordance was obtained at genotype level using both regions except for two samples where putative 1–4 recombinants/multiple infections were detected. Therefore, HCV genotyping based on at least two genomic regions could help to identify putative recombinants and improve therapeutic management of HCV infection.

16 November 2018 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
SKSebastien Kenmoe
Sebastien Kenmoe
PNPaul Alain TAGNOUOKAM NGOUPO
Paul Alain TAGNOUOKAM NGOUPO
CNCyprien Kengne Nde
Cyprien Kengne Nde
GMGhislaine Flore Mella-Tamko
Ghislaine Flore Mella-Tamko
RNRichard Njouom
Richard Njouom
Dried blood spots (DBS) offer multiple benefits for collecting, storing and shipping whole blood samples. Our objective was to compare, for the first time in Africa, the performance of DBS with respect to plasma in the detection of Hepatitis B surface antigen (HBsAg) and antibodies to Hepatitis C Virus (anti-HCV) using Architect, Abbott Diagnostics. DBS had a sensitivity of 99%, a specificity of 100%, a positive predictive value of 99%, a negative predictive value of 100% and a kappa index of 0.99 for the detection of HBsAg. For anti-HCV detection, the sensitivity, specificity, positive predictive value, negative predictive value and kappa index were 99%, 98%, 98%, 99%, and 0.97, respectively. This study confirms that DBS may be a reliable alternative specimen type for HBV and HCV diagnosis.

2 December 2022 in Science
Verified
Journal Article
Closed access
CFCarlo Fischer
Carlo Fischer
TMTongai Gibson Maponga
Tongai Gibson Maponga
AYAnges Yadouleton
Anges Yadouleton
NANuro Abílio
Nuro Abílio
EAEmmanuel Aboce
Emmanuel Aboce
JDJan-Felix Drexler
Jan-Felix Drexler
The geographic and evolutionary origins of the SARS-CoV-2 Omicron variant (BA.1), which was first detected mid-November 2021 in Southern Africa, remain unknown. We tested 13,097 COVID-19 patients sampled between mid-2021 to early 2022 from 22 African countries for BA.1 by real-time RT-PCR. By November-December 2021, BA.1 had replaced the Delta variant in all African sub-regions following a South-North gradient, with a peak Rt of 4.1. Polymerase chain reaction and near-full genome sequencing data revealed genetically diverse Omicron ancestors already existed across Africa by August 2021. Mutations, altering viral tropism, replication and immune escape, gradually accumulated in the spike gene. Omicron ancestors were therefore present in several African countries months before Omicron dominated transmission. These data also indicate that travel bans are ineffective in the face of undetected and widespread infection.

12 February 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAbdou Fatawou Modiyinji
Abdou Fatawou Modiyinji
LTLange Tchamba Amorgathe Tankeu
Lange Tchamba Amorgathe Tankeu
CMChavely Gwladys Monamele
Chavely Gwladys Monamele
MMMoise Henri Yifomnjou Moumbeket
Moise Henri Yifomnjou Moumbeket
PNPaul Alain TAGNOUOKAM NGOUPO
Paul Alain TAGNOUOKAM NGOUPO
RNRichard Njouom
Richard Njouom
Background: Febrile jaundice is a common indicator of certain infectious diseases, including hepatitis E. In Cameroon, the yellow fever virus is the only pathogen that is monitored in patients who present with this symptom. However, more than 90% of the samples received as part of this surveillance are negative for yellow fever. This study aimed to describe the prevalence and hepatitis E virus (HEV) genotype among yellow fever-negative patients in the Far North and West regions of Cameroon. Methods: In a cross-sectional study, yellow fever surveillance-negative samples collected between January 2021 and January 2023 were retrospectively analyzed. Anti-HEV IgM and IgG antibodies were tested using commercially available ELISA kits. Anti-HEV IgM and/or IgG positive samples were tested for HEV RNA by real-time RT-PCR, followed by nested RT-PCR, sequencing and phylogenetic analysis. Results: Overall, 121 of the 543 samples (22.3%, 95% CI: 19.0% - 26.0%) were positive for at least one anti-HEV marker. Amongst these, 8.1% (44/543) were positive for anti-HEV IgM, 5.9% (32/543) for anti-HEV IgG, and 8.3% (45/544) for both markers. A total of 15.2% (12/79) samples were positive for HEV RNA real-time RT-PCR and 8 samples were positive for HEV RNA by nested RT-PCR. Phylogenetic analysis showed that the retrieved sequences clustered within HEV genotypes/subtypes 1/1e, 3/3f and 4/4b. Conclusion: Our results showed that HEV is one of the causes of acute febrile jaundice in patients enrolled in the yellow fever surveillance program in two regions of Cameroon. We described the circulation of three HEV genotypes, including two zoonotic genotypes. Further studies will be important to elucidate the transmission routes of these zoonotic HEV genotypes to humans in Cameroon.